Who would have predicted that one of the hottest trends for beleaguered biotechs in 2025 would be to rebrand as a crypto company?

Leap Therapeutics has became the latest drug developer to make the move, transforming this morning into Cypherpunk Technologies and focusing on its hoard of $50 million worth of a digital currency called ZEC.